“Seed oils are not inherently inflammatory and don't need to be avoided; on their own they are a healthy source of polyunsaturated fat, and it's highly processed foods, not the seed oils in them, that should be limited." (Slide text: "SEED OILS ARE INFLAMMATORY AND SHOULD BE AVOIDED" [crossed-out myth framing] / "Seed oils on their own…”

The central mechanistic argument made by seed oil critics is that linoleic acid converts to arachidonic acid and then to pro-inflammatory eicosanoids. The retrieved evidence addresses this directly. The 2012 systematic review of randomized controlled trials in healthy, non-infant humans concluded there is "virtually no evidence" from randomized intervention studies that adding linoleic acid to the diet increases concentrations of inflammatory markers. A related systematic review of 36 trials (Rett & Whelan, 2011) found that increasing dietary linoleic acid did not increase tissue arachidonic acid content in adults eating Western-type diets, which undercuts the proposed mechanism at its first step. The Journal of Nutrition analysis of the Aegis cohort, covering roughly 1,900 people, found higher serum omega-6 PUFA and linoleic acid were inversely associated with inflammatory biomarkers. The lead investigator, Kevin Maki, stated that higher plasma linoleic acid was associated with lower levels of biomarkers of inflammation and cardiometabolic risk. This is cross-sectional and therefore associational only. The pooled analysis of 30 prospective cohort studies from 13 countries examined circulating and adipose tissue linoleic acid and arachidonic acid against incident cardiovascular disease, using harmonized individual-level data. Reviews and institutional summaries characterize the overall observational picture as showing higher linoleic acid levels associated with lower, not higher, risk of cardiometabolic disease and premature death. The 2025 Frontiers in Nutrition review of the controversy concluded that most human evidence supports a protective association between linoleic acid intake and cardiovascular and metabolic outcomes, while noting that potential adverse effects of oxidized derivatives of linoleic acid warrant further investigation. On the ultra-processed food attribution: the American Heart Association's news arm quoted Stanford's Christopher Gardner saying the real concern should be overeating ultra-processed foods, which may contain harmful ingredients such as high-fructose corn syrup, added sugar and sodium, and that seed oils are not the problem in those foods. NPR quoted Sarah Berry and Gardner making the same point, that seed oils cannot be singled out for the correlation with poor outcomes because ultra-processed foods are typically high in multiple other ingredients known to drive poor health. Johns Hopkins convened a media briefing in October 2025 on exactly this distinction, and coverage of it reported the expert position that seed oils are not unhealthy on their own. One notable editorial detail: the AHA article carries a correction stating that an earlier version incorrectly described omega-6 as pro-inflammatory. That correction is itself evidence of how entrenched the inflammation assumption has been, including at authoritative outlets. ## METHODOLOGY AND CONTEXT **Evidence hierarchy applied here.** The inflammation question is answered at a relatively strong level: randomized controlled trials pooled in a systematic review, which is the appropriate design for a causal claim about a dietary exposure changing a biomarker. The disease-outcome question rests more heavily on observational cohorts and biomarker analyses, which are weaker for causation. **Populations and intakes.** The 2012 RCT review was restricted to healthy, non-infant humans. It does not address people with existing inflammatory conditions, nor extreme intakes far outside normal dietary ranges. **What the Cochrane review actually found.** The 2018 Cochrane review of omega-6 fats is the most important piece of nuance and it cuts against the post's most enthusiastic framing. It reported no evidence that increasing omega-6 fats reduces cardiovascular outcomes other than myocardial infarction, where approximately 53 people would need to increase omega-6 intake to prevent one MI. That is a finding of limited demonstrated benefit. It is not a finding of harm, and it does not support avoidance, but it is a meaningful check on the word "healthy." **Counter-evidence examined.** The two studies most often cited by seed oil critics are the Sydney Diet Heart Study and the Minnesota Coronary Experiment. The 2016 BMJ re-analysis of recovered Minnesota Coronary Experiment data concluded that incomplete publication had contributed to overestimating the benefits of replacing saturated fat with linoleic-acid-rich vegetable oils. That is a claim about overstated benefit, not about seed oils causing harm, and the trials are decades old with recognized limitations, including the fact that the Sydney trial's intervention involved margarine that would have contained trans fats now universally accepted as harmful. **Unresolved mechanistic questions.** The oxidized linoleic acid metabolite question, relevant to repeatedly heated or deep-fried oil, remains flagged in the peer-reviewed literature as needing further study. Separately, NPR's reporting noted that most commodity seed oil extraction uses heat and chemical solvents rather than mechanical pressing, which is a processing fact, not by itself a demonstrated health outcome. **Claim source status.** The post is by a self-identified Registered Dietitian. Credentials do not verify a claim, but they are consistent with the claim being an accurate restatement of mainstream professional guidance rather than an invented statistic. The post cites no specific study, so there is no numeric claim to trace.